http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102011366-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-027 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
filingDate | 2017-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102011366-B1 |
titleOfInvention | Method for screening metastasis inhibitor for cancer |
abstract | The present invention can screen cancer metastasis inhibitors with high accuracy by measuring the expression level of hyaluronic acid synthase 2 in cancer-mesenchymal stem-like cells isolated from cancer patients. In addition, the present invention can predict the metastasis potential of cancer with high accuracy by comparing the expression levels of hyaluronic acid synthase 2 and hyaluronic acid synthase 1 or 3 in cancer-mesenchymal stem-like cells isolated from cancer patients. |
priorityDate | 2016-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1272.